Immutep Selects Charles River Laboratories for IMP761's GLP

Media Release Appointment of Charles River Laboratories to run Immutep’s preclinical toxicology study evaluating the safety and toxicity of IMP761Forms a key step prior to... | May 29, 2023

Related Keywords

Australia , Sydney , New South Wales , Australian , Chris Basta , Immutep Limited , Globenewswire Inc , Corporate Communications , Nasdaq , Charles River Laboratories , Charles River , Chief Scientific Officer , Lymphocyte Activation , Investor Relations , Immutep Limited Stock Exchange , News , Information , Press Release , Media , Release , Appointment , F , Charles , Liver , Laboratories , O , Fun , Reclinical , Toxicology , Study , Valuating , The , Safety , End , Toxicity , Mp761forms , Key , Step , Rior Imm Au000000imm6 ,